A convenient, bio-inspired approach to the synthesis of multi-functional, stable fluorescent silica nanoparticles using poly(ethylene-imine)

Cationic polymeric template-mediated preparation of silica nanocomposites

Biosilicification allows the formation of complex and delicate biogenic silica in near-neutral solutions under ambient conditions. Studies have revealed that, during biosilicification, basic amino acid residues and long-chain polyamines of organic substrates interact electrostatically with negatively charged silicate precursors in solution, catalyzing the polycondensation of silicic acid and accelerating the formation of silica. This mechanism has inspired researchers to explore polymers bearing chemical similarity with these organic matrices as cationic templates for biomimetic silicification. Such templates can be classified into two general categories based on the physical forms applied. One is a solution of water-soluble cationic polymers, either natural or synthetic, used as is for silicification. The other category includes various microscopically shaped entities made of cationic polymer-containing molecules, in the form of micelles, vesicles, crystalline aggregates, latex particles, and microgels. Combined with controlled polymerization and other techniques, these preorganized templates can be tailor designed in terms of sizes and morphologies to allow further expansion of properties and functions. In this review, notable research progress for both categories of silicification under biomimetic conditions is discussed. With the merits of silica and cationic polymers seamlessly integrated, the potential of such versatile nanocomposites in biomedical as well as energy and environmental applications is also briefly highlighted.

Mitochondria-targeted nanoparticles (mitoNANO): An emerging therapeutic shortcut for cancer

The early understanding of mitochondria posited that they were 'innocent organelles' solely devoted to energy production and utilisation. Intriguingly, recent findings have outlined in detail the 'modern-day' view that mitochondria are an important but underappreciated drug target. Mitochondria have been implicated in the pathophysiology of many human diseases, ranging from neurodegenerative disorders and cardiovascular diseases to infections and cancer. It is now clear that normal mitochondrial function involves the building blocks of a cell to generate lipids, proteins and nucleic acids thereby facilitating cell growth. On the other hand, mitochondrial dysfunction reprograms crucial cellular functions into pathological pathways, and is considered as an integral hallmark of cancer. Therefore, strategies to target mitochondria can provide a wealth of new therapeutic approaches in the fight against cancer, by overcoming a number of problems associated with conventional pharmaceutical drugs, including low solubility, poor bioavailability and non-selective biodistribution. The combination of nanoparticles with 'classical' chemotherapeutic drugs to create biocompatible, multifunctional mitochondria-targeted nanoplatforms has been recently studied. This approach is now rapidly expanding for targeted drug delivery systems, and for hybrid nanostructures that can be activated with light (photodynamic and/or photothermal therapy). The selective delivery of nanoparticles to mitochondria is an elegant shortcut to more selective, targeted, and safer cancer treatment. We propose that the use of nanoparticles to target mitochondria be termed "mitoNANO". The present minireview sheds light on the design and application of mitoNANO as advanced cancer therapeutics, that may overcome drug resistance and show fewer side effects.

Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates

Rationale: Both spatial accuracy and temporal persistence are crucial in drug delivery, especially for anti-tumor intravenous nanomedicines, which have limited persistence due to their small particle sizes and easy removal from tumors. The present study takes advantage of morphological transformation strategy to regulate intravenous nanomedicines to display different sizes in different areas, achieving high efficient enrichment and long retention in lesions. Methods: We designed and synthesized functional doxorubicin-peptide conjugate nanoparticles (FDPC-NPs) consisting of self-assembled doxorubicin-peptide conjugates (DPCs) and an acidic-responsive shielding layer named the functional polylysine graft (FPG), which can regulate the assembly morphology of the DPCs from spherical DPC nanoparticles (DPC-NPs) to DPC-nanofibers (DPC-NFs) by preventing the assembly force from π-π stacking and hydrogen bond between the DPC-NPs. The morphology transformation and particle changes of FDPC-NPs in different environments were determined with DLS, TEM and SEM. We used FRET to explore the enhanced retention effect of FDPC-NPs in tumor site in vivo. HPLC-MS/MS analytical method was established to analyze the biodistribution of FDPC-NPs in H22 hepatoma xenograft mouse model. Finally, the antitumor effect and safety of FDPC-NPs was evaluated. Results: The FDPC-NPs were stable in blood circulation and responsively self-assembled into DPC-NFs when the FDPC-NPs underwent the acid-sensitive separation of the shielding layer in a mildly acidic microenvironment. The FDPC-NPs maintained a uniform spherical size of 80 nm and exhibited good morphological stability in neutral aqueous solution (pH 7.4) but aggregated into a long necklace-like chain structure or a crosslinked fiber structure over time in a weakly acidic solution (pH 6.5). These acidity-triggered transformable FDPC-NPs prolonged the accumulation in tumor tissue for more than 5 days after a single injection and improved the relative uptake rate of doxorubicin in tumors 31-fold. As a result, FDPC-NPs exhibited a preferable anti-tumor efficacy and a reduced side effect in vivo compared with free DOX solution and DOX liposomes. Conclusions: Morphology-transformable FDPC-NPs represent a promising therapeutic approach for prolonging the residence time of drugs at the target site to reduce side effect and enhance therapeutic efficacy. Our studies provide a new and simple idea for the design of long-term delivery systems for intravenous chemotherapeutic drugs.

Amine Functionalization of Silica Sol-Gel Thin Films via Kinetic Doping: A Novel, Green Approach

Amine-functionalized thin films are highly desirable technologies for analytical, material, and biochemistry applications. Current functionalization procedures can be costly, environmentally unfriendly, and require many synthetic steps. Here, we present an inexpensive and facile way to functionalize a silica thin film with a 25 000 MW branched polyethylenimine (BPEI), consistent with green chemistry principles. Using UV-vis spectroscopy and scanning electron microscopy, BPEI was determined to be loaded into the film at an approximately 0.5 M concentration, which is a 500× increase from the loading solution used. The films were also tested for copper(II) sequestration to assess their potential for heavy metal sequestration and showed a high loading capacity of 10 ± 6 mmol/g. Films proved to be reusable, using ethylenediaminetetraacetic acid to chelate copper and regenerate the films, with only a 6% reduction in the amount of copper(II) ions sequestered by the third use. The films also proved stable against leaching over the course of 1 week in solution, with less than 1% of the original BPEI lost under various storage conditions (i.e., storage in deionized (DI) water, storage in dilute BPEI solution, storage in DI water after annealing). These films show promise for multiple applications, from heavy metal sequestration to antifouling applications, while being inexpensive, facile, and environmentally friendly to synthesize. To our knowledge, this is the first time that BPEI has been doped into silica thin films.